Whether you're new to exercise or looking to improve your routine, small adjustments can dramatically improve results. These three practical strategies can help you train smarter, avoid injuries, and ...

Teledyne Technologies Incorporated (NYSE:TDY), a global leader in advanced imaging and sensor solutions, is pleased to announce the start of production on multiple awards to deliver state-of-the-art ...

(The Center Square) - Armenian-speakers in Los Angeles County utilize California’s In-Home Supportive Services program at a rate roughly 700% higher than their proportion of the county’s population, ...

Baseline Therapeutics, Inc. (“Baseline”), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of ...

John Dorer is CEO of New York City-based EB3.work, a staffing consultancy that helps employers fill positions when they can’t hire locally. Opinions are the author’s own. The labor shortage in the ...

The MarketWatch News Department was not involved in the creation of this content. -- Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

United for Libraries and Penguin Random House will award grants of $500 and $1,000 (totaling $25,000) to support libraries in need. Specifically, grant funds will assist Friends of Library groups with ...

The Grand Junction Lions Club kicked off its annual Random Acts of Kindness program in its Tuesday meeting at Warehouse 25sixty-five. As part of the program, club members who attended the meeting were ...

The UK is prepared to cancel its £6.3 billion ($8.4 billion) Ajax program, Defence Secretary John Healey said, after the army halted its use of the armored vehicles built by General Dynamics UK Ltd ...

First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI’s registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, ...